Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Historical Holders from Q4 2018 to Q3 2025

Symbol
ETON on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
26,828,643
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
17,672,584
Holdings value
$384,025,414
% of all portfolios
0.001%
Number of holders
101
Number of buys
51
Number of sells
-38
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EcoR1 Capital, LLC 7.7% $28,407,583 1,981,003 EcoR1 Capital, LLC 31 Dec 2024
BlackRock, Inc. 5.7% $21,807,587 1,530,357 BlackRock, Inc. 30 Jun 2025
VANGUARD GROUP INC 5.01% $29,207,619 1,344,115 The Vanguard Group 30 Sep 2025

Institutional Holders of Eton Pharmaceuticals, Inc. - Common Stock (ETON)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 17,672,584 $384,025,414 +$23,406,418 $21.73 101
2025 Q2 16,549,306 $235,826,915 +$35,134,963 $14.25 85
2025 Q1 14,123,114 $183,315,077 +$11,955,184 $12.98 85
2024 Q4 13,135,396 $174,958,469 +$42,338,294 $13.32 70
2024 Q3 9,507,414 $57,043,272 +$8,311,784 $6 47
2024 Q2 8,228,308 $27,068,977 +$3,401,849 $3.29 44
2024 Q1 7,182,688 $26,933,962 -$87,277 $3.75 43
2023 Q4 7,158,411 $31,363,548 +$1,218,504 $4.38 55
2023 Q3 6,899,800 $28,769,681 +$3,931,364 $4.17 50
2023 Q2 5,976,427 $20,857,388 +$424,606 $3.49 33
2023 Q1 5,838,481 $22,478,563 +$148,362 $3.85 34
2022 Q4 5,937,571 $18,150,958 -$813,830 $2.82 31
2022 Q3 6,343,985 $13,321,785 +$813,651 $2.1 29
2022 Q2 5,916,510 $17,660,917 +$786,718 $2.62 28
2022 Q1 5,783,483 $27,369,526 +$1,310,432 $4.36 29
2021 Q4 5,731,001 $24,586,557 -$1,088,577 $4.29 30
2021 Q3 5,962,287 $32,572,856 -$1,717,167 $5.04 35
2021 Q2 3,148,485 $22,473,059 -$10,316,735 $6.16 42
2021 Q1 8,785,097 $67,961,804 +$530,664 $7.32 48
2020 Q4 8,725,390 $74,997,463 +$13,790,621 $8.13 45
2020 Q3 7,034,912 $59,521,869 +$2,214,437 $7.9 38
2020 Q2 6,803,798 $39,802,008 +$5,744,437 $5.45 40
2020 Q1 5,967,575 $24,469,000 +$13,430,167 $4.1 17
2019 Q4 2,623,150 $18,886,000 +$2,667,626 $7.2 13
2019 Q3 2,277,530 $14,392,000 +$3,218,363 $6.31 14
2019 Q2 1,767,833 $13,965,000 +$2,101,428 $7.9 10
2019 Q1 1,501,083 $12,008,000 +$2,806,319 $8 12
2018 Q4 1,151,824 $7,048,000 +$7,048,000 $6.12 11